| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/02/2007 | WO2007085750A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/02/2007 | WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
| 08/02/2007 | WO2007085679A1 Preparation of beta-carboline from natural products and foods having monoaminooxidase (mao) inhibiting activity |
| 08/02/2007 | WO2007085558A1 Use of 2-imidazoles for the treatment of cns disorders |
| 08/02/2007 | WO2007085556A2 Use of 4-imidazole derivatives for cns disorders |
| 08/02/2007 | WO2007085453A1 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis |
| 08/02/2007 | WO2007085357A1 Cyclourea compounds as calcium channel blockers |
| 08/02/2007 | WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease |
| 08/02/2007 | WO2007085036A1 Treatment of friedreich' s ataxia |
| 08/02/2007 | WO2007069925A3 Non-neurotoxic recreational drugs and a method of treating recreational drug abuse |
| 08/02/2007 | WO2007065713A3 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders |
| 08/02/2007 | WO2007057691A3 Therapeutic uses of steroidal compounds |
| 08/02/2007 | WO2007052104A3 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 08/02/2007 | WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 08/02/2007 | WO2007048220A3 Trazodone composition for once a day adminisitiation |
| 08/02/2007 | WO2007044809A3 Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use |
| 08/02/2007 | WO2007031440A3 2-aniline-4-aryl substituted thiazole derivatives |
| 08/02/2007 | WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 08/02/2007 | WO2006131923A3 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 08/02/2007 | WO2006130676A3 Inhibition of neuronal damage |
| 08/02/2007 | WO2006121919A3 Methods of treating obsessive compulsive disorder |
| 08/02/2007 | WO2006112552A3 Therapeutic agents for abeta related disorders |
| 08/02/2007 | WO2006112551A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179172 Positive modulators of nicotinic acetylcholine receptors |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179141 Therapeutic agents useful for treating pain |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070178587 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178467 Gm1 promoter and use thereof |
| 08/02/2007 | US20070178174 Neuroprotective/neurostimulatory use of Cistanche extract |
| 08/02/2007 | US20070178119 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | DE102006004142A1 Use of colony-stimulating factors for treating or preventing coma and neurotoxicity, including apallic or locked-in syndromes and poisoning by amphetamine derivatives |
| 08/02/2007 | DE102006004008A1 Treating or preventing multiple sclerosis comprises administering erythropoietin for periods separated by intervals in which no erythropoietin is administered |
| 08/02/2007 | CA2640223A1 Methods and compositions for treating schizophrenia |
| 08/02/2007 | CA2640213A1 2-[6-(methylamino)pyridine-3-yl]-1,3-benzothiazole-6-ol for measuring an anyloid deposit |
| 08/02/2007 | CA2637312A1 Use of substituted 2-imidazole of imidazoline derivatives |
| 08/02/2007 | CA2637308A1 Use of 4-imidazole derivatives for cns disorders |
| 08/02/2007 | CA2637261A1 Use of 2-imidazoles for the treatment of cns disorders |
| 08/02/2007 | CA2636787A1 Novel histidine derivatives |
| 08/02/2007 | CA2635920A1 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813606A1 Amide compound |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1813283A1 Remedy for neuropathic pain |
| 08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 08/01/2007 | EP1812451A2 Compounds and methods of use thereof |
| 08/01/2007 | EP1812439A2 Kinase inhibitors |
| 08/01/2007 | EP1812428A2 Zolmitriptan crystal forms |
| 08/01/2007 | EP1812420A1 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 08/01/2007 | EP1812416A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 08/01/2007 | EP1812408A2 Pyridazine compounds, compositions and methods |
| 08/01/2007 | EP1812398A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 08/01/2007 | EP1812390A2 Methylphenidate analogs and methods of use thereof |
| 08/01/2007 | EP1812389A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/01/2007 | EP1812112A2 Chemical compounds |
| 08/01/2007 | EP1812070A1 Treatment of restless legs syndrome |
| 08/01/2007 | EP1812050A1 Composition comprising vlp and amyloid-beta peptide |
| 08/01/2007 | EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 08/01/2007 | EP1812009A1 Gaba-steroid antagonists and their use for the treatment of cns disorders |
| 08/01/2007 | EP1811995A1 A transmucosal veterinary composition comprising detomidine |
| 08/01/2007 | EP1811973A1 Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1537124B1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1461037B1 Process for preparation of a beverage treated with a nicotine containing substance |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1372681B1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1330468B1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 08/01/2007 | EP1303277B1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence |
| 08/01/2007 | EP1294722B1 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1248609A4 Method of treating benign forgetfulness |
| 08/01/2007 | EP1032389B1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 08/01/2007 | CN1329413C Antibody for treating or preventing senile dementia, its expression vector and application in drug preparation |
| 08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
| 08/01/2007 | CN1329396C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | CN1329393C New purine derivatives |
| 08/01/2007 | CN1329389C Novel compounds and their use |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329073C Chinese medicinal composition for relieving alcoholism |
| 08/01/2007 | CN1329070C Health care and refreshing brain towel treated with Chinse medicinal solution and its production |
| 08/01/2007 | CN1329036C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |